Research Focus

Former Employee. Graduate Staff; Special Fellow

Recent additions – View all

1. KEYNOTE-555 Cohort B: Efficacy, safety, and PK of pembrolizumab (pembro) 400 mg every 6 weeks (Q6W) as 1L therapy for advanced melanoma

   Meeting Abstract

   Jacobs, C. R.; Rapoport, B. L.; Chan, S. W.; Ruff, P.; Arance, A. M.; Mujika, K.; Anderson, J. R.; Lala, M.; Jain, L.; Akala, O. O.; more...
   Journal of Clinical Oncology (2021)

   Fulltext@MSK | Save
2. High frequency mismatch repair (MMR) pathway mutations in adrenocortical carcinoma: Indication for routine MMR-deficiency (MMR-D) testing

   Meeting Abstract

   Akala, O. O.; Kelly, V.; Strong, V. E.; Gopalan, A.; Reidy, D. L.; Raj, N. P.
   Journal of Clinical Oncology (2018)

   Fulltext@MSK | Save
3. Widespread somatic loss of heterozygosity as a possible marker of disease aggressiveness in metastatic well differentiated pancreatic neuroendocrine tumors

   Meeting Abstract

   Akala, O. O.; Shah, R.; Untch, B. R.; Kelly, V.; Chou, J. F.; Ladanyi, M.; Berger, M. F.; Klimstra, D. S.; Reidy, D. L.; Raj, N. P.
   Journal of Clinical Oncology (2018)

   Fulltext@MSK | Save